Intelligent Ultrasound Group appoints Ingeborg Øie to its Board as Non-Executive Director

– UK, Cardiff –  Intelligent Ultrasound Group plc (LON: IUG), the ultrasound artificial intelligence software and simulation company, today announced the appointment of Ingeborg Øie to its Board as a Non-Executive Director.

Ingeborg will join the Audit Committee and newly formed ESG Working Group, effective with her appointment.

“I am delighted that Ingeborg has chosen to join Intelligent Ultrasound as a Non-executive Director. She was an outstanding candidate for the position and her experience and passion for impacting global health outcomes can only benefit the Group, as we continue to expand our business from the classroom to the clinic.” said Board Chairman, Riccardo Pigliucci.

About Ingeborg Øie

Ingeborg Øie brings to the Company outstanding financial, corporate governance, and investor relations experience, having been a medical devices and healthcare services analyst at Goldman Sachs and Jefferies and she is currently CFO of next-generation surgical robotics company, CMR Surgical. She was also a Non-executive Director of Georgia Healthcare Group, the largest healthcare services provider in Georgia, that before its acquisition by Georgia Capital Plc in 2020, was listed on the London Stock Exchange.

About Intelligent Ultrasound Group

Intelligent Ultrasound develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:

Clinical AI Division
Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include:

ScanNav Assist
ScanNav Assist uses machine-learning-based algorithms to automatically identify and grade ultrasound images. GE Healthcare’s SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received 510(k) clearance from the FDA for sale in the USA. SonoLyst is the world’s first fully integrated AI tool that recognizes the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.

ScanNav Anatomy
ScanNav Anatomy PNB uses machine-learning-based algorithms to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting software for a range of medical procedures. ScanNav Anatomy has received CE approval and has also been submitted for FDA regulatory approval.

ScanNav Anatomy PNB is therefore not available for sale in the US or any other territory requiring government approval for this type of product.

Simulation Division
Focusses on hi-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module, and the new AI-based Anatomy PNB training simulator. To date over 1,000 simulators have been sold to over 600 medical institutions around the world.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.